At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 111 enrolled
Drug / intervention
MR-107A-02 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Response Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.
In Brief
A Phase 2 clinical trial evaluating MR-107A-02 and Placebo for Acute Pain and 2 related conditions. Completed, enrolled 111 participants across 1 site.
Detailed Summary
MR-107A-02 is being studied to investigate its efficacy, safety and dose-response after dental surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain, Post Operative Pain, Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2023202420252026
Enrollment StartMar 2022
First PostedApr 2022
Primary CompletionJun 2022
Study CompletionJun 2022
TodayJul 2026
First PostedApr 7, 2022
Enrollment StartMar 31, 2022
Primary CompletionJun 15, 2022
Study CompletionJun 20, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.2 years ago
Interventions
MR-107A-02drug
MR-107A-02 oral tablet
Placebodrug
Placebo oral tablet